BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1974500)

  • 1. Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.
    Nagakawa Y; Akedo Y; Kaku S; Orimo H
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S115-9. PubMed ID: 1974500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
    Omvik P; Lund-Johansen P; Myking O
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T; Snowden R; Butcher L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic profile of carvedilol.
    Hombach V; Kochs M; Höher M; Eggeling T; Haerer W; Wieshammer S; Schmidt A
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S101-3. PubMed ID: 1974496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of carvedilol on the hemodynamics and its tolerance in elderly patients].
    Asai T; Kuzuya M; Koike A; Kanda S; Maeda K; Iguchi A
    Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):187-92. PubMed ID: 11974943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Sivertsson R; Andrén L; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
    Eggertsen R; Sivertsson R; Andrén L; Hansson L
    J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pentoxifylline on hemodynamic, hemorheological, and microcirculatory parameters in young SHRs during arterial hypertension development.
    Plotnikov MB; Aliev OI; Shamanaev AY; Sidekhmenova AV; Anfinogenova Y; Anishchenko AM; Fomina TI; Arkhipov AM
    Clin Exp Hypertens; 2017; 39(6):570-578. PubMed ID: 28722518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension.
    Kuriyama Y; Nakamura M; Kyougoku I; Sawada T
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S120-1. PubMed ID: 1974501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between arterial blood pressure and blood viscosity in spontaneously hypertensive rats treated with pentoxifylline.
    Plotnikov MB; Aliev OI; Nosarev AV; Shamanaev AY; Sidekhmenova AV; Anfinogenova Y; Anishchenko AM; Pushkina EV
    Biorheology; 2016 Jul; 53(2):93-107. PubMed ID: 27472841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.
    Abbott JA; Broadstone RV; Ward DL; Pyle RL
    Am J Vet Res; 2005 Apr; 66(4):637-41. PubMed ID: 15900944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Andrén L; Sivertsson R; Hansson L
    Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation.
    Ruffolo RR; Sauermelch CF; Willette RN
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S112-4. PubMed ID: 1974499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.